Strategic Opportunity Position YourChoice Therapeutics as a target for investors and corporate partners in the non-hormonal contraception space, highlighting their early-stage clinical trials, recent BIO International Convention activity, and notable Series A funding to attract potential collaborators and co-development deals.

Clinical Momentum Emphasize ongoing non-hormonal birth control and male fertility product development, with recent phase 1a trial results and a public launch of an early-stage human study, to create partnerships with contract research organizations, clinical trial sites, and fertility-focused distributors.

Market Readiness Leverage the niche focus on non-hormonal solutions to position for partnerships with healthcare providers, women’s health clinics, and fertility centers seeking differentiated contraceptive options, backed by a clear growth narrative and potential for multi-product adoption.

Funding Leverage Utilize the $15M Series A funding and strategic investors to approach larger biopharma and specialty pharma companies for licensing, co-development, or distribution agreements, reinforcing scale-up opportunities and market entry plans.

Regional Focus Highlight Berkeley, California base and agile startup profile with a small team to attract boutique and mid-sized biotech players for collaboration on manufacturing, supply chain, and commercialization pilots in both US and international markets.